How are HCV-infected patients being identified in Brazil: a multicenter study

Detalhes bibliográficos
Autor(a) principal: Portari-Filho,Luiz H.
Data de Publicação: 2019
Outros Autores: Álvares-da-Silva,Mario R., Gonzalez,Aline, Ferreira,Adalgisa P., Nogueira,Cristiane V., Mendes-Correa,Maria C., Lima,José M., Lopes,Edmundo P., Brandão,Carlos E., Ivantes,Cláudia, Lyra,André, Lindenberg,Andreia, Ferraz,Maria L.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Infectious Diseases
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702019000100034
Resumo: ABSTRACT Background: Hepatitis C is an important health problem. In Brazil, 1-2 million people are infected. Despite this expressive number, and the availability of very successful treatment, many patients remained undiagnosed mainly because of the asymptomatic nature of the infection. Objectives: To describe epidemiological characteristics of HCV-infected patients seen at referral centers in Brazil, the source of referral, and the time spanned to reach a reference center, in order to improve the identification of undiagnosed patients. Methods: Multicenter observational, cross-sectional study carried out in 15 centers of Brazil, between January/2016 and June/2017. Data of patients with a confirmed diagnosis (anti-HCV and HCV-RNA) were collected by interview using standard questionnaires and by review of charts. Results: Two thousand patients were included; 55.1% were male, mean age 58 ± 11 years. Only 14.9% had higher education and 84.2% received up to five monthly minimum Brazilian wages (approximately US$260.00/month). The time between diagnosis and beginning of follow-up was 22.9 months. The most common reasons for testing were check-up (33.2%) and blood donation (19%). General practitioners diagnosed most of the patients (30.1%). Fibrosis stage was mainly evaluated by liver biopsy (61.5%) and 31.3% of the patients were cirrhotic at diagnosis. Conclusions: This multicenter Brazilian study showed that the mean time to reach a referral center for treatment was almost two years. Primary care physicians diagnoses most hepatitis C cases in the country. Population campaigns and medical education should be encouraged to intensify screening of asymptomatic individuals, considering the efficiency of check-ups in identifying new patients.
id BSID-1_62c11a825d8c695a0aa1d5823f8181d3
oai_identifier_str oai:scielo:S1413-86702019000100034
network_acronym_str BSID-1
network_name_str Brazilian Journal of Infectious Diseases
repository_id_str
spelling How are HCV-infected patients being identified in Brazil: a multicenter studyEpidemiologyhepatitis CHCVBrazilABSTRACT Background: Hepatitis C is an important health problem. In Brazil, 1-2 million people are infected. Despite this expressive number, and the availability of very successful treatment, many patients remained undiagnosed mainly because of the asymptomatic nature of the infection. Objectives: To describe epidemiological characteristics of HCV-infected patients seen at referral centers in Brazil, the source of referral, and the time spanned to reach a reference center, in order to improve the identification of undiagnosed patients. Methods: Multicenter observational, cross-sectional study carried out in 15 centers of Brazil, between January/2016 and June/2017. Data of patients with a confirmed diagnosis (anti-HCV and HCV-RNA) were collected by interview using standard questionnaires and by review of charts. Results: Two thousand patients were included; 55.1% were male, mean age 58 ± 11 years. Only 14.9% had higher education and 84.2% received up to five monthly minimum Brazilian wages (approximately US$260.00/month). The time between diagnosis and beginning of follow-up was 22.9 months. The most common reasons for testing were check-up (33.2%) and blood donation (19%). General practitioners diagnosed most of the patients (30.1%). Fibrosis stage was mainly evaluated by liver biopsy (61.5%) and 31.3% of the patients were cirrhotic at diagnosis. Conclusions: This multicenter Brazilian study showed that the mean time to reach a referral center for treatment was almost two years. Primary care physicians diagnoses most hepatitis C cases in the country. Population campaigns and medical education should be encouraged to intensify screening of asymptomatic individuals, considering the efficiency of check-ups in identifying new patients.Brazilian Society of Infectious Diseases2019-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702019000100034Brazilian Journal of Infectious Diseases v.23 n.1 2019reponame:Brazilian Journal of Infectious Diseasesinstname:Brazilian Society of Infectious Diseases (BSID)instacron:BSID10.1016/j.bjid.2019.01.006info:eu-repo/semantics/openAccessPortari-Filho,Luiz H.Álvares-da-Silva,Mario R.Gonzalez,AlineFerreira,Adalgisa P.Nogueira,Cristiane V.Mendes-Correa,Maria C.Lima,José M.Lopes,Edmundo P.Brandão,Carlos E.Ivantes,CláudiaLyra,AndréLindenberg,AndreiaFerraz,Maria L.eng2019-05-16T00:00:00Zoai:scielo:S1413-86702019000100034Revistahttps://www.bjid.org.br/https://old.scielo.br/oai/scielo-oai.phpbjid@bjid.org.br||lgoldani@ufrgs.br1678-43911413-8670opendoar:2019-05-16T00:00Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)false
dc.title.none.fl_str_mv How are HCV-infected patients being identified in Brazil: a multicenter study
title How are HCV-infected patients being identified in Brazil: a multicenter study
spellingShingle How are HCV-infected patients being identified in Brazil: a multicenter study
Portari-Filho,Luiz H.
Epidemiology
hepatitis C
HCV
Brazil
title_short How are HCV-infected patients being identified in Brazil: a multicenter study
title_full How are HCV-infected patients being identified in Brazil: a multicenter study
title_fullStr How are HCV-infected patients being identified in Brazil: a multicenter study
title_full_unstemmed How are HCV-infected patients being identified in Brazil: a multicenter study
title_sort How are HCV-infected patients being identified in Brazil: a multicenter study
author Portari-Filho,Luiz H.
author_facet Portari-Filho,Luiz H.
Álvares-da-Silva,Mario R.
Gonzalez,Aline
Ferreira,Adalgisa P.
Nogueira,Cristiane V.
Mendes-Correa,Maria C.
Lima,José M.
Lopes,Edmundo P.
Brandão,Carlos E.
Ivantes,Cláudia
Lyra,André
Lindenberg,Andreia
Ferraz,Maria L.
author_role author
author2 Álvares-da-Silva,Mario R.
Gonzalez,Aline
Ferreira,Adalgisa P.
Nogueira,Cristiane V.
Mendes-Correa,Maria C.
Lima,José M.
Lopes,Edmundo P.
Brandão,Carlos E.
Ivantes,Cláudia
Lyra,André
Lindenberg,Andreia
Ferraz,Maria L.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Portari-Filho,Luiz H.
Álvares-da-Silva,Mario R.
Gonzalez,Aline
Ferreira,Adalgisa P.
Nogueira,Cristiane V.
Mendes-Correa,Maria C.
Lima,José M.
Lopes,Edmundo P.
Brandão,Carlos E.
Ivantes,Cláudia
Lyra,André
Lindenberg,Andreia
Ferraz,Maria L.
dc.subject.por.fl_str_mv Epidemiology
hepatitis C
HCV
Brazil
topic Epidemiology
hepatitis C
HCV
Brazil
description ABSTRACT Background: Hepatitis C is an important health problem. In Brazil, 1-2 million people are infected. Despite this expressive number, and the availability of very successful treatment, many patients remained undiagnosed mainly because of the asymptomatic nature of the infection. Objectives: To describe epidemiological characteristics of HCV-infected patients seen at referral centers in Brazil, the source of referral, and the time spanned to reach a reference center, in order to improve the identification of undiagnosed patients. Methods: Multicenter observational, cross-sectional study carried out in 15 centers of Brazil, between January/2016 and June/2017. Data of patients with a confirmed diagnosis (anti-HCV and HCV-RNA) were collected by interview using standard questionnaires and by review of charts. Results: Two thousand patients were included; 55.1% were male, mean age 58 ± 11 years. Only 14.9% had higher education and 84.2% received up to five monthly minimum Brazilian wages (approximately US$260.00/month). The time between diagnosis and beginning of follow-up was 22.9 months. The most common reasons for testing were check-up (33.2%) and blood donation (19%). General practitioners diagnosed most of the patients (30.1%). Fibrosis stage was mainly evaluated by liver biopsy (61.5%) and 31.3% of the patients were cirrhotic at diagnosis. Conclusions: This multicenter Brazilian study showed that the mean time to reach a referral center for treatment was almost two years. Primary care physicians diagnoses most hepatitis C cases in the country. Population campaigns and medical education should be encouraged to intensify screening of asymptomatic individuals, considering the efficiency of check-ups in identifying new patients.
publishDate 2019
dc.date.none.fl_str_mv 2019-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702019000100034
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702019000100034
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.bjid.2019.01.006
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
dc.source.none.fl_str_mv Brazilian Journal of Infectious Diseases v.23 n.1 2019
reponame:Brazilian Journal of Infectious Diseases
instname:Brazilian Society of Infectious Diseases (BSID)
instacron:BSID
instname_str Brazilian Society of Infectious Diseases (BSID)
instacron_str BSID
institution BSID
reponame_str Brazilian Journal of Infectious Diseases
collection Brazilian Journal of Infectious Diseases
repository.name.fl_str_mv Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)
repository.mail.fl_str_mv bjid@bjid.org.br||lgoldani@ufrgs.br
_version_ 1754209244623667200